Comments

Palisade Bio Stock Price, Quotes and Forecasts

Q: What sector and industry does Palisade Bio (PALI) operate in?

Palisade Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

PALINASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$0.8479

0.011.30%

At close: -

$0.8490

0.001100.13%

After Hours: Mar 7, 7:03 AM EDT

Palisade Bio (PALI) Forecast

News Earnings Palisade Bio (PALI) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Palisade Bio Stock Price, Quotes and Forecasts | NASDAQ:PALI | Benzinga

Explore Palisade Bio stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PALI.

Open	$0.83
Close	$0.85
Volume / Avg.	16.91K / 1.60M
Day Range	$0.82 - $0.86
52 Wk Range	0.75 - 9.65
Market Cap	$2.52M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	27
Short Interest	3.88%
Days to Cover	1

Recent News

What's Going On With Palisade Bio Stock On Thursday?

Palisade Bio progresses its Phase 1 study for PALI-2108, showing safety and targeted bioactivation, with topline data anticipated in early 2025.

Vandana Singh

Nasdaq Down 50 Points; US Initial Jobless Claims Rise

Avi Kapoor

Why DBV Technologies Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.83
Close	$0.85
Volume / Avg.	16.91K / 1.60M
Day Range	$0.82 - $0.86
52 Wk Range	0.75 - 9.65
Market Cap	$2.52M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	27
Short Interest	3.88%
Days to Cover	1

About Palisade Bio Inc

Sector

Health Care

Industry

Biotechnology

Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therape...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Palisade Bio (PALI) stock?

You can purchase shares of Palisade Bio (NASDAQ:PALI) through any online brokerage.

View our list of the best stock brokerages

Who are Palisade Bio (PALI) competitors?

Other companies in Palisade Bio’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Vincerx Pharma (NASDAQ:VINC), Tharimmune (NASDAQ:THAR), Entero Therapeutics (NASDAQ:ENTO) and Quoin Pharmaceuticals (NASDAQ:QNRX).

What is the forecast, or price target, for Palisade Bio (PALI) stock?

Palisade Bio has a consensus price target of $20.67.

What is the current price for Palisade Bio (PALI)?

The stock price for Palisade Bio (NASDAQ: PALI) is $0.849 last updated March 7, 2025 at 7:03 AM EST.

Does Palisade Bio (PALI) pay a dividend?

There are no upcoming dividends for Palisade Bio.

When is Palisade Bio (NASDAQ:PALI) reporting earnings?

Palisade Bio’s Q1 earnings are confirmed for Monday, May 12, 2025.

Is Palisade Bio (PALI) going to split?

There is no upcoming split for Palisade Bio.

What sector and industry does Palisade Bio (PALI) operate in?

Palisade Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.